What is Big Think?  

We are Big Idea Hunters…

We live in a time of information abundance, which far too many of us see as information overload. With the sum total of human knowledge, past and present, at our fingertips, we’re faced with a crisis of attention: which ideas should we engage with, and why? Big Think is an evolving roadmap to the best thinking on the planet — the ideas that can help you think flexibly and act decisively in a multivariate world.

A word about Big Ideas and Themes — The architecture of Big Think

Big ideas are lenses for envisioning the future. Every article and video on bigthink.com and on our learning platforms is based on an emerging “big idea” that is significant, widely relevant, and actionable. We’re sifting the noise for the questions and insights that have the power to change all of our lives, for decades to come. For example, reverse-engineering is a big idea in that the concept is increasingly useful across multiple disciplines, from education to nanotechnology.

Themes are the seven broad umbrellas under which we organize the hundreds of big ideas that populate Big Think. They include New World Order, Earth and Beyond, 21st Century Living, Going Mental, Extreme Biology, Power and Influence, and Inventing the Future.

Big Think Features:

12,000+ Expert Videos

1

Browse videos featuring experts across a wide range of disciplines, from personal health to business leadership to neuroscience.

Watch videos

World Renowned Bloggers

2

Big Think’s contributors offer expert analysis of the big ideas behind the news.

Go to blogs

Big Think Edge

3

Big Think’s Edge learning platform for career mentorship and professional development provides engaging and actionable courses delivered by the people who are shaping our future.

Find out more
Close

Finally, a Universal Flu Vaccine?

July 30, 2011, 8:30 AM
Flu_man_

What's the Latest Development?

Swiss immunologist Antonio Lanzavecchia says that observing the human immune response to influenza convinced him that it would be possible to design a vaccine that prevails over mutation. During the 2009 N1H1 flu pandemic, Lanzavecchia discovered that some people had antibodies that inactivate all influenza A subtypes. After examining over 100,000 white blood cells, he and his team developed a special antibody: "Our FI6 antibody is the first one ever found that reacts to all 16 of the influenza A subtypes,' says Lanzavecchia."

What's the Big Idea?

The new antibody itself is not a vaccine, but it could be an instruction manual for making one. The scientists say that a small protein mimicking the part of the virus bound by the FI6 antibody might cajole the immune system into making similarly cross-reactive antibodies. And while Lanzavecchia admits that developing the FI6 binding site into a new vaccine may take years, he hopes that the antibody itself might be used as a treatment in the meantime. The treatment has so far been successful in treating mice and ferrets.

 

Finally, a Universal Flu Va...

Newsletter: Share: